Chicago Partners Investment Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,643
Closed -$172K 945
2024
Q4
$172K Buy
13,643
+4,547
+50% +$79.9K 0.01% 823
2024
Q3
$204K Sell
9,096
-1,019
-10% -$26.3K 0.01% 759
2024
Q2
$240K Buy
10,115
+2,311
+30% +$59K 0.01% 656
2024
Q1
$235K Buy
7,804
+453
+6% +$14.5K 0.01% 643
2023
Q4
$228K Buy
+7,351
New +$208K 0.01% 614
2023
Q2
Sell
-5,750
Closed -$203K 693
2023
Q1
$203K Buy
+5,750
New +$182K 0.01% 612
2017
Q1
Sell
-300
Closed -$4K 562
2016
Q4
$4K Hold
300
﹤0.01% 473
2016
Q3
$7K Hold
300
﹤0.01% 439
2016
Q2
$6K Hold
300
﹤0.01% 400
2016
Q1
$3K Hold
300
﹤0.01% 402
2015
Q4
$4K Hold
300
﹤0.01% 453
2015
Q3
$5K Hold
300
﹤0.01% 385
2015
Q2
$6K Buy
+300
New +$5.59K ﹤0.01% 380

Other funds holding EVH

Chicago Partners Investment Group's EVH Position: Q1 2025 in Review

Chicago Partners Investment Group sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 13,643 shares — an estimated $172K sold.

Chicago Partners Investment Group first reported a position in EVH in Q2 2015 and held it in 13 quarters. The position peaked at $240K in Q2 2024. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Chicago Partners Investment Group reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Chicago Partners Investment Group sold 13,643 Evolent Health shares in Q1 2025, an estimated $172K.
  • Chicago Partners Investment Group first reported a position in Evolent Health in Q2 2015 and held it in 13 quarters.
  • Chicago Partners Investment Group's Evolent Health position peaked at $240K in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Chicago Partners Investment Group's 13F filing for Q1 2025, filed 9 May 2025.